Response to growth hormone

pathway activity — cross-omics
GO:0060416Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Response to growth hormone pathway is significantly associated with the RNA expression of multiple genes, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are GYPC, DNAJA3, and THOP1, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Response to growth hormone activity versus GYPC in GBM (Pearson r = 0.39).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMGYPC →+0.637+0.169.001.00135
LSCCDNAJA3 →-0.460-0.266<.001<.00134
LSCCTHOP1 →-0.513-0.227<.001.00434
LSCCUBQLN4 →-0.510-0.236.002.00334
LSCCVRK1 →-0.568-0.199.001.00134
LSCCMAZ →-0.397-0.245.009.00734
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0060416 vs GYPC — GBM

Per-sample scatter of Response to growth hormone activity vs GYPC in GBM.

Explore this scatter interactively →

Exploration